New Delhi: Reacting to a TOI report on the conflict of interest of Central Pollution Control Board chairman, environment and forests minister Jayanthi Natarajan has said she will inquire into the f

With only four years remaining in which to achieve the key targets of the Millennium Development Goals (MDGs), most of the world’s Heads of State and Government came to the United Nations in September 2010 to take stock of progress made thus far.

New Delhi: Chairman of the Central Pollution Control Board S P Gautam sold a patent he held privately on a technology to the apex authority on a revenue sharing basis and then passed a directive in

Pfizer Inc and Dr Reddy’s Laboratories have settled a patent infringement suit related to the Indian drug maker’s launch of a generic version of the blockbuster drug, Lipitor, in the US.

The final hearings have started at the Supreme Court regarding Swiss drug-major Novartis' blood cancer drug Glivec.

For more than two hundred years, the world has discussed the issue of whether to continue the process of patenting or whether to do away with it. Developed countries remain polarized for various reasons but nevertheless the pro patent regime continued. The result was a huge volume of patents. The present article explains the implications of excessive volume of patents and conditions under which prior art search fails. This article highlights the importance and necessity of standardization efforts so as to bring about convergence of views on patenting.


Developing countries will now have to battle IP issues related to new agricultural technologies at WIPO instead of WTO.

In a closely watched case, a federal appeals court ruled on Friday that genes can be patented, overturning a lower court decision that had shocked the biotechnology industry.

Three scientists from the National Chemical Laboratory (NCL) in Pune, Amol Arvindrao Kulkarni, Dattatraya Dethe and Rahul Banerjee, have been selected for the Young Scientist Award 2011, instituted by the Council for Industrial and Scientific Research (CSIR).

The award carries a cash prize and a citation and will be presented to them on September 26, CSIR Foundation Day, in New Delhi.


Gilead Sciences has become the first pharmaceutical company to set up a licensing agreement with the recently-established Medicines Patent Pool (MPP), in a move aimed toward increasing access in developing countries to drugs that treat HIV and Hepatitis B.